Related Experiment Video
Updated: Mar 29, 2026

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
Published on: August 29, 2012
[Ocular graft-versus-host disease]
T Dietrich-Ntoukas1, P Steven2,3
1Klinik für Augenheilkunde, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Deutschland. tina.dietrich-ntoukas@charite.de.
Ocular graft-versus-host disease (GvHD) after stem cell transplant causes severe dry eye and potential blindness. Early, individualized, multidisciplinary treatment is crucial for managing this inflammatory ocular surface disorder.
Area of Science:
- Ophthalmology
- Hematology
- Oncology
Background:
- Ocular graft-versus-host disease (GvHD) is an inflammatory ocular surface disorder with increasing incidence following allogeneic hematopoietic stem cell transplantation (HSCT).
- This condition significantly impacts quality of life due to dry eye syndromes and can lead to visual impairment and blindness from corneal complications.
- Ocular GvHD is characterized by severe, therapy-resistant ocular surface dryness and chronic inflammation.
Purpose of the Study:
- To highlight the challenges in managing ocular GvHD.
- To emphasize the importance of multimodal, stage-related, and interdisciplinary therapeutic approaches.
Main Methods:
- Review of current understanding of ocular GvHD pathophysiology and clinical presentation.
- Discussion of therapeutic strategies and the need for collaboration between ophthalmologists, hematologists, and oncologists.
Main Results:
- Ocular GvHD presents significant challenges due to its inflammatory nature and resistance to conventional treatments.
- Corneal complications are a major concern, potentially leading to irreversible vision loss.
- Effective management requires a comprehensive, individualized approach tailored to disease stage.
Conclusions:
- Ocular GvHD necessitates prompt diagnosis and management to prevent vision-threatening complications.
- An interdisciplinary, multimodal therapeutic strategy is essential for optimal patient outcomes.
- Close collaboration among specialists is key to addressing the complexities of ocular GvHD treatment.
More Related Videos
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Angle Closure Glaucoma: Treatment
Cytomegalovirus Disease
Kidney Transplant I: Introduction